Literature DB >> 19293131

Increased expression of ac-FoxO1 protein in prelabor fetal membranes overlying the cervix: possible role in human fetal membrane rupture.

Martha Lappas1, Clyde Riley, Greg E Rice, Michael Permezel.   

Abstract

Forkhead box O proteins have critical roles in a number of cellular processes, including apoptosis. Acetylation and phosphorylation of forkhead box O proteins are posttranslational modifications that attenuate their transcriptional activity. As supracervical fetal membranes are characterized by increased cell death, the aim of this study was to compare the expression of forkhead box O1, acetylated-forkhead box O1, and Ser-256 phosphorylated forkhead box O1 at supracervical and distal site fetal membrane. Fetal membranes overlying the cervix were identified in situ in women undergoing term elective Caesarean section. Immunohistochemistry (n = 7) was used to analyze the protein expression of forkhead box O1, acetylated-forkhead box O1, and Ser-256 phosphorylated forkhead box O1. There was no difference in forkhead box O1 and Ser-256 phosphorylated forkhead box O1 protein expression between the 2 sites. However, when compared with distal site, the intensity and extent of staining of acetylated-forkhead box O1 were greater in amnion and chorion obtained from the supracervical site. In summary, supracervical fetal membranes are characterized by increased acetylated-forkhead box O1 protein expression. Although the precise role and contribution of acetylated-forkhead box O1 in the process of human fetal membrane rupture are unknown, it has been implicated in apoptosis and/or cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293131     DOI: 10.1177/1933719109332831

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  8 in total

1.  Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term.

Authors:  Chia-Ling Nhan-Chang; Roberto Romero; Adi L Tarca; Pooja Mittal; Juan Pedro Kusanovic; Offer Erez; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; John Hotra; Nandor Gabor Than; Jung-Sun Kim; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

Review 2.  Extracellular matrix dynamics and fetal membrane rupture.

Authors:  Jerome F Strauss
Journal:  Reprod Sci       Date:  2012-01-19       Impact factor: 3.060

3.  In-vivo stretch of term human fetal membranes.

Authors:  E M Joyce; P Diaz; S Tamarkin; R Moore; A Strohl; B Stetzer; D Kumar; M S Sacks; J J Moore
Journal:  Placenta       Date:  2015-12-20       Impact factor: 3.481

4.  The impact of vitamin C supplementation in pregnancy and in vitro upon fetal membrane strength and remodeling.

Authors:  Brian M Mercer; Adli Abdelrahim; Robert M Moore; Jillian Novak; Deepak Kumar; Joseph M Mansour; Marina Perez-Fournier; Cynthia J Milluzzi; John J Moore
Journal:  Reprod Sci       Date:  2010-07       Impact factor: 3.060

5.  Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro.

Authors:  R M Moore; F Schatz; D Kumar; B M Mercer; A Abdelrahim; N Rangaswamy; C Bartel; J M Mansour; C J Lockwood; J J Moore
Journal:  Placenta       Date:  2010-08-14       Impact factor: 3.481

Review 6.  Human fetal membranes at term: Dead tissue or signalers of parturition?

Authors:  Ramkumar Menon
Journal:  Placenta       Date:  2016-05-29       Impact factor: 3.481

7.  Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells.

Authors:  Ratana Lim; Gillian Barker; Clyde Riley; Martha Lappas
Journal:  Reprod Sci       Date:  2013-01-11       Impact factor: 3.060

8.  Magnetic resonance imaging of the supra-cervical fetal membrane detects an increased risk of prelabor rupture of membranes.

Authors:  Wenxu Qi; Peinan Zhao; Wei Wang; Zichao Wen; Zhexian Sun; Wenjie Wu; Pamela Karen Woodard; Qing Wang; Robert C McKinstry; Yong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.